The Prescription Review Program (PRP) (2006) is Saskatchewan’s prescription monitoring program.
It monitors for apparent inappropriate prescribing and inappropriate use of a provincially designated panel of monitored prescription drugs which have been deemed subject to misuse or abuse in the province. A list of these monitored prescription drugs, or “PRP medications”, can be found in Bylaw 18.1.
The Program has the ability to review all PRP medication prescriptions that have been filled in the province over the last 12 years.
Its method of operation is educationally based. The Program sends out alert letters to prescribers when possible misuse of PRP medications is identified. When apparent inappropriate prescribing and/or use of a medication is identified, an explanation is required from the prescriber for the diagnosis, indications for use, and medical rationale for prescribing and whether appropriate safeguards are in place as outlined by Canadian standards and guidelines to prevent potential misuse. Based on the responses, utilization of the Canadian standards and guidelines for the prescribing of these medications, recommendations are presented to the prescriber for consideration of possible management changes. As the Program is part of the medical regulatory and licensing body for the province, the prescriber is obligated under legislation to respond to these inquiries. The authorities of the Prescription Review Program are identified within the Regulatory Bylaws of the College of Physicians and Surgeons of Saskatchewan.
In addition to the program report provided in the College’s yearly Annual Report, the PRP program also provides a detailed report for the Ministry of Health. See below for more information.
2012 Annual Report
2013 Annual Report
2014 Annual Report
2015 Annual Report
Pharmacist Manager: Julia Bareham